USP29 is a novel non-canonical Hypoxia Inducible Factor-α activator
A. S. Schober, I. Martin-Barros, T. Martin-Mateos, E. Perez-Andres, O. Carlevaris, S. Pozo, A. R. Cortazar, A. M. Aransay, A. Carracedo, U. Mayor, V. See, E. Berra
This study identifies USP29 as a non-canonical activator of HIF-α that stabilizes HIF-1 and HIF-2 independently of oxygen, PHD, and pVHL, and correlates with disease progression in prostate cancer.
bioRxiv · Feb 20, 2020 · PreprintCell Biology